All Stories

  1. Why do people have different paths of functional loss over the life course?
  2. How primary care is essential for optimizing the function of the whole health system.
  3. Linked Sensitivity Analysis, Calibration, and Uncertainty Analysis Using a System Dynamics Model for Stroke Comparative Effectiveness Research
  4. Short-Term Trajectories of Depressive Symptoms in Stroke Survivors and Their Family Caregivers
  5. Future requirements for and supply of ophthalmologists for an aging population in Singapore
  6. A comparison of utilization of family, home and residential services primarily European countries.
  7. Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation
  8. Abstract 3732: Detecting germline PTEN mutations among at-risk cancer patients: An age and gender-specific cost effectiveness analysis
  9. The impact of population dynamics and foreign labour policy on dependency: the case of Singapore
  10. Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis
  11. APSC2015-1166 The Effect of a Standardized Protocol in Right-Siting and Cardiovascular Risk Factor Control in Patients After Successful Percutaneous Coronary Intervention
  12. Projecting the effect of education on rates of older individuals with functional disability
  13. Sample size calculations for the design of cluster randomized trials: A summary of methodology
  14. Gender, educational and ethnic differences in active life expectancy among older Singaporeans
  15. Self-Care for Older People (SCOPE): A cluster randomized controlled trial of self-care training and health outcomes in low-income elderly in Singapore
  16. Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: Data from the Chinese Longitudinal Healthy Longevity Survey
  17. Atrial fibrillation in China
  18. Optimal Management of Riata Leads with No Known Electrical Abnormalities or Externalization: A Decision Analysis
  19. Demographic and Structural Determinants of Successful Aging in Singapore
  20. Vitamin D Levels and Cognition in Elderly Adults in China
  21. The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial
  22. Presence of and correction for interviewer error on an instrument assessing cognitive function of older adults
  23. Implications of long-term care capacity response policies for an aging population: A simulation analysis
  24. Simulating the Impact of Long-Term Care Policy on Family Eldercare Hours
  25. Expert estimates of caregiver hours for older Singaporeans with dementia
  26. Chapter 1: Introduction to the Methods Guide for Medical Test Reviews
  27. Chapter 5: Assessing Risk of Bias as a Domain of Quality in Medical Test Studies
  28. Chapter 7: Grading a Body of Evidence on Diagnostic Tests
  29. Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests used as Predictive Indicators
  30. Methods Guide for Authors of Systematic Reviews of Medical Tests: A Collaboration Between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine
  31. Future living arrangements of Singaporeans with age-related dementia
  32. Depressive symptoms among informal caregivers of older adults: insights from the Singapore Survey on Informal Caregiving
  33. Contemporary Outcome Measures in Acute Stroke Research
  34. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
  35. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study)
  36. Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program
  37. Stakeholders’ perspective on issues and challenges associated with care and treatment of aging-related cognitive impairment disorders in Singapore
  38. The Chronic Kidney Disease Model: A General Purpose Model of Disease Progression and Treatment
  39. Effect of Home Testing of International Normalized Ratio on Clinical Events
  40. Geographic Variation in Carotid Revascularization Among Medicare Beneficiaries, 2003-2006
  41. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481–The Home INR Study (THINRS)
  42. Cytochrome P450 testing in the treatment of depression
  43. Clinical Effectiveness of Coronary Stents in Elderly Persons
  44. Hypertension Improvement Project (HIP): study protocol and implementation challenges
  45. The Headache Management Trial: A Randomized Study of Coordinated Care
  46. Standards for Measures Used for Public Reporting of Efficiency in Health Care
  47. Strategies for Incorporating Resource Allocation and Economic Considerations *
  48. Outcomes of Second Revascularization Procedures after Stent Implantation
  49. Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
  50. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors
  51. Cost-effectiveness Analysis of Strategies for Diagnosing Celiac Disease
  52. Noninvasive imaging for coronary artery disease: A technology assessment for the Medicare Coverage Advisory Commission
  53. Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
  54. Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
  55. AB4-5
  56. Changing Physician Knowledge, Attitudes, and Beliefs About Migraine: Evaluation of a New Educational Intervention
  57. Facilitated Process Improvement: An Approach to the Seamless Linkage Between Evidence and Practice in CKD
  58. Improving the process of developing technical reports for health care decision-makers: Using the Theory of Constraints in the Evidence-Based Practice Centers
  59. Evidence-Based Practice Center network and health technology assessment in the United States: Bridging the cultural gap
  60. A NEW ERA IN EPILEPSY CARE Guidelines address first steps in diagnosis and treatment
  61. A Cost-Minimization Analysis Comparing Azithromycin-Based and Levofloxacin-Based Protocols for the Treatment of Patients Hospitalized With Community-Acquired Pneumonia
  62. Cost-Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty
  63. Burden of Illness and Satisfaction With Care Among Patients With Headache Seen in a Primary Care Setting
  64. Dissemination of Evidence-based Practice Center Reports
  65. The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481—The Home INR Study (THINRS)
  66. Meta-Analysis of Survival and Relief of Angina Pectoris After Transmyocardial Revascularization
  67. FDG-PET for management of cervical and ovarian cancer
  68. How can modeling best contribute to the assessment of secondary stroke prevention strategies?
  69. Health Policy and Outcomes Research 2004
  70. Testing for von Willebrand Disease in Women With Menorrhagia: A Systematic Review
  71. P2-350 Costs associated with increasing severity of dementia — A review of the literature
  72. When to Stress Over Triptans: A Markov Analysis of Cardiovascular Risk in Migraine Treatment
  73. Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine
  74. How strong is the relationship between functional status and quality of life among persons with stroke?
  75. Do Anticoagulation Management Services Improve Care? Implications of the Managing Anticoagulation Services Trial
  76. Making evidence-based practice improvement more than a comforting sentiment
  77. When Should Functional Neuroimaging Techniques Be Used in the Diagnosis and Management of Alzheimer's Dementia? A Decision Analysis
  78. Headache Management Program Improves Outcome for Chronic Headache
  79. Cross-Calibration of Stroke Disability Measures
  80. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial
  81. Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT)
  82. Managing Oral Anticoagulant Therapy
  83. Toward Evidence-Based Management of Migraine
  84. New Transient Ischemic Attack and Stroke
  85. Treating QALYs With a Heavy Dose of Social Values: Is the Cure Worth the Cost?
  86. Quality of Anticoagulation Management Among Patients With Atrial Fibrillation
  87. INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI: A DECISION ANALYTICAL VIEW
  88. INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI
  89. Performing Cost-Effectiveness Analysis by Integrating Randomized Trial Data with a Comprehensive Decision Model
  90. Determining Clinically Important Differences in Health Status Measures
  91. Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke
  92. Physician-reported readiness to change stroke prevention practices
  93. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions
  94. Treatment considerations for persons with metastatic prostate cancer: Survival versus out-of-pocket costs
  95. Combining Patient Utility with Health Status Assessment to Improve Medical Decision Making
  96. Combining Patient Utility with Health Status Assessment to Improve Medical Decision Making
  97. Should we just let the anticoagulation service do it?
  98. Cost‐effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?
  99. Cost-effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?
  100. Cost-effectiveness of Collecting Routine Cytologic Specimens During Fiberoptic Bronchoscopy for Endoscopically Visible Lung Tumor
  101. Stroke Prevention Guidelines
  102. Theories Explaining Racial Differences in the Utilization of Diagnostic and Therapeutic Procedures for Cerebrovascular Disease
  103. Performance of the Serum Cobalamin Assay for Diagnosis of Cobalamin Deficiency
  104. Management of Atrial Fibrillation
  105. Medical Treatment for Stroke Prevention
  106. Likelihood ratios for continuous test results—making the clinicians' job easier or harder?
  107. The Influence of Hyperglycemia on Outcome of Cerebral Infarction
  108. Response
  109. Predicting the outcomes of electrophysiologic studies of patients with unexplained syncope
  110. Likelihood ratios with confidence: Sample size estimation for diagnostic test studies
  111. Symposium Introduction: Technology Assessment and Guideline Development: Concerns and Opportunities for Academic General Internists
  112. Decision Making in the Face of Uncertainty: The Case of Carotid Endarterectomy
  113. Routine intravenous pyelograms before hysterectomy in cases of benign disease: Possibly effective, definitely expensive
  114. Endarterectomy in Carotid Artery Disease
  115. Isotope-Dilution Assay for Urinary Methylmalonic Acid in the Diagnosis of Vitamin B 12 Deficiency